November 26, 2020
Business News

A little-known biotech working on a COVID-19 vaccine has surged 304% in 2 days — and it just said it was .. – Business Insider

Reuters

  • Vaxart, a small-cap biotechnology company focused on developing oral vaccines administered by tablet rather than injection, said on Friday that it had been selected for the US govern…

    Click here to view the original article.

Related Posts

You might also like ...

Office Furniture Market to Grow by $ 22.67 bn During 2020-2024 | Industry Analysis, Market Trends, Market Growth, Opportunities, and Forecast 2024 | Technavio
Best Black Friday & Cyber Monday Surface Book Deals (2020): Best Microsoft Surface Book 3 & 2 Sales Monitored by The Consumer Post
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality